Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART
- PMID: 29121665
- PMCID: PMC5679639
- DOI: 10.1371/journal.pone.0186912
Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART
Abstract
HIV-infected migrants were shown to have poorer treatment outcomes than Dutch HIV-infected patients, often due to worse treatment adherence. Self-reported adherence would be an easy way to monitor adherence, but its validity relative to pharmacy refill adherence has not been extensively evaluated in migrants. All HIV-infected migrants older than 18 years and in care at the two Rotterdam HIV-treatment centers were eligible. Refill data with leftover medication (PRL) (residual pill count) were obtained from their pharmacies up to 15 months prior to inclusion. Self-reported adherence to combination Antiretroviral Therapy was assessed by four questions about adherence at inclusion. Additionally, risk factors for pharmacy refill non-adherence were examined. In total, 299 HIV-infected migrants were included. Viral load (VL) was detectable in 11% of the patients. Specificity of PRL was 53% for patients with an adherence of 100% and decreased with lower cut-off values. Sensitivity and negative predictive value (NPV) were 68% and 15% and increased with lower cut-off values. Positive predictive value (PPV) was around 93% for all cut-off values. Using the self-reported questions, 139 patients (47%) reported to be adherent. Sensitivity was 49% and specificity was 72%. PPV and NPV were 95% and 13%. No risk factors for pharmacy refill non-adherence were found in multivariable analyses. Both PRL and self-reported adherence, can predict undetectable VL in HIV-infected migrants. PPV and NPV are similar for both methods. This study shows that using four self-reported items is sufficient to predict adherence which is crucial for optimal clinical outcome in HIV-infected migrants.
Conflict of interest statement
Similar articles
-
Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?Trop Med Int Health. 2016 Jul;21(7):856-69. doi: 10.1111/tmi.12709. Epub 2016 May 18. Trop Med Int Health. 2016. PMID: 27118068
-
Predicting viral load suppression by self-reported adherence, pharmacy refill counts and real time medication monitoring among people living with HIV in Tanzania.AIDS Res Ther. 2022 Nov 15;19(1):51. doi: 10.1186/s12981-022-00475-y. AIDS Res Ther. 2022. PMID: 36380383 Free PMC article. Clinical Trial.
-
Sub-optimal adherence to combination anti-retroviral therapy and its associated factors according to self-report, clinician-recorded and pharmacy-refill assessment methods among HIV-infected adults in Addis Ababa.AIDS Care. 2017 Apr;29(4):428-435. doi: 10.1080/09540121.2016.1234681. Epub 2016 Oct 4. AIDS Care. 2017. PMID: 27701908
-
Comparison of the predictive performance of adherence measures for virologic failure detection in people living with HIV: a systematic review and pairwise meta-analysis.AIDS Care. 2019 Jun;31(6):647-659. doi: 10.1080/09540121.2018.1554241. Epub 2018 Dec 5. AIDS Care. 2019. PMID: 30516060
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
Cited by
-
Factors associated with adherence to antiretroviral therapy among HIV-positive adolescents and young adult patients attending HIV care and treatment clinic at Bombo Hospital in Tanga region-Tanzania.PLoS One. 2025 Jan 3;20(1):e0316188. doi: 10.1371/journal.pone.0316188. eCollection 2025. PLoS One. 2025. PMID: 39752421 Free PMC article.
-
Adherence to Antiretroviral Therapy and Associated Factors Among People Living With HIV Following the Introduction of Dolutegravir Based Regimens in Dar es Salaam, Tanzania.J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221084543. doi: 10.1177/23259582221084543. J Int Assoc Provid AIDS Care. 2022. PMID: 35243923 Free PMC article.
-
Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series.AIDS Res Ther. 2022 Nov 26;19(1):56. doi: 10.1186/s12981-022-00477-w. AIDS Res Ther. 2022. PMID: 36435793 Free PMC article.
-
Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria.AIDS Res Ther. 2022 Jul 10;19(1):35. doi: 10.1186/s12981-022-00462-3. AIDS Res Ther. 2022. PMID: 35820913 Free PMC article.
-
Health-Related Quality of Life in Young Adults With Perinatal HIV After Transfer to Adult Health Care in the Netherlands.J Acquir Immune Defic Syndr. 2024 Dec 15;97(5):514-521. doi: 10.1097/QAI.0000000000003526. Epub 2024 Nov 5. J Acquir Immune Defic Syndr. 2024. PMID: 39261985 Free PMC article.
References
-
- Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, Yip B, et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009;50(5):529–36. doi: 10.1097/QAI.0b013e31819675e9 - DOI - PMC - PubMed
-
- Ochieng W, Kitawi RC, Nzomo TJ, Mwatelah RS, Kimulwo MJ, Ochieng DJ, et al. Implementation and Operational Research: Correlates of Adherence and Treatment Failure Among Kenyan Patients on Long-term Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2015;69(2):e49–56. doi: 10.1097/QAI.0000000000000580 - DOI - PMC - PubMed
-
- Beer L, Skarbinski J. Adherence to antiretroviral therapy among HIV-infected adults in the United States. AIDS Educ Prev. 2014;26(6):521–37. doi: 10.1521/aeap.2014.26.6.521 - DOI - PMC - PubMed
-
- Safren SA, Mayer KH, Ou SS, McCauley M, Grinsztejn B, Hosseinipour MC, et al. Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples. J Acquir Immune Defic Syndr. 2015;69(2):234–40. doi: 10.1097/QAI.0000000000000593 - DOI - PMC - PubMed
-
- Nellen JF, Wit FW, De Wolf F, Jurriaans S, Lange JM, Prins JM. Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands. J Acquir Immune Defic Syndr. 2004;36(4):943–50. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical